Melanotan I
A melanocortin-1 agonist approved in defined photoprotection indications.
- Molecule class
- Alpha-MSH analogue (afamelanotide)
- Category
- Melanocortin
- Market prevalence
- 4 of 9 catalogues
What this page does not tell you
No evidence review has been completed for Melanotan I. This page therefore contains no evidence grade, no claim about what it does, no quantity, no duration, and no interaction assessment. The description above states what the molecule is, not what it has been shown to do. Its presence in this catalogue is a record that other sites list it, and is not a statement about it in either direction.
Market presence
Listed on 4 of 9 reference catalogues
How widely a compound is sold and written about. This measures commercial distribution, not scientific support, and the two frequently diverge.
- peptidedosingprotocols.comdoes not list this compound
- lotilabs.comdoes not list this compound
- purehealthpeptides.comdoes not list this compound
- bluewavecompounds.comlists this compound
- corepeptidesdirect.comlists this compound
- peptidescalculator.comdoes not list this compound
- thepeptidealmanac.comlists this compound
- pathtopeptides.comdoes not list this compound
- peptideprotocolportal.comlists this compound
Naming
Names it is sold or listed under
Compounds are frequently listed under abbreviations, blend names, or vendor-specific labels. These were resolved to one canonical entry during cataloguing.
- Afamelanotide
Next step
Go to the primary literature yourself
Rather than summarise research we have not yet reviewed, we send you to the source. When reading what you find, the questions that matter most are whether any of it is human evidence, how large and how long the studies were, and whether the route studied matches the route being sold.
Same category